Analystreport

Ionis Pharmaceuticals (NASDAQ:IONS) had its price target raised by analysts at TD Cowen from $59.00 to $99.00. They now have a "buy" rating on the stock.

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com